Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study

BACKGROUND: Giant cell tumor of the bone (GCTB) is classified as an intermediate, locally aggressive but rarely metastasizing tumor. The mainstay of treatment for the treatment of GCTB had been the surgical removal until an anti- receptor activator of nuclear factor-kappa B ligands (RANKL) antibody...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMC Musculoskelet Disord
Prif Awduron: Takeuchi, Akihiko, Tsuchiya, Hiroyuki, Ishii, Takeshi, Nishida, Yoshihiro, Abe, Satoshi, Matsumine, Akihiko, Kawai, Akira, Yoshimura, Kenichi, Ueda, Takafumi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2016
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4957292/
https://ncbi.nlm.nih.gov/pubmed/27448567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-016-1163-z
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg